Investegate |Polarean Imaging PLC Announcements | Polarean Imaging PLC: FDA Approves XENOVIEWT (Xe 129 hyperpolarized)

Investegate announcements from Polarean Imaging PLC, FDA Approves XENOVIEWT (Xe 129 hyperpolarized)

Related Keywords

United States ,Cincinnati ,Ohio ,Americans ,Nick Adams Harland ,Kenneth West ,Anna Dunphy Phillip ,Richard Hullihen ,Stifel Nicolaus Europe Limited ,Cincinnati Children Medical Center ,Drug Administration ,Customer Care Center ,Polarean Imaging Plc ,Polarean Inc ,Chief Executive Officer ,Jason Woods ,Pulmonary Medicine ,Cincinnati Children ,Medical Center ,Chest Coil ,Trial Results ,Decreased Image Quality ,Supplemental Oxygen ,Transient Hypoxia ,Adult Patients ,Adolescent Patients ,Nicolaus Europe Limited ,Sole Corporate Broker ,Samira Essebiyea ,Kate Hanshaw ,Healthcare Investment Banking ,Nick Harland ,Corporate Broking ,Phillip Marriage ,Investegate Announcements ,Investegate Company Announcements ,Egulatory News Service ,Egulatory News Service And Regulatory ,Ns ,